These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Remission of facial and scalp hyperhidrosis with clonidine hydrochloride and topical aluminum chloride. Torch EM South Med J; 2000 Jan; 93(1):68-9. PubMed ID: 10653070 [TBL] [Abstract][Full Text] [Related]
24. The use of transdermal clonidine in the hypertensive patient with chronic renal failure. Lowenthal DT; Saris SD; Paran E; Cristal N Clin Nephrol; 1993 Jan; 39(1):37-43. PubMed ID: 8428406 [TBL] [Abstract][Full Text] [Related]
28. Exposure to topical apraclonidine in children with glaucoma. Wright TM; Freedman SF J Glaucoma; 2009; 18(5):395-8. PubMed ID: 19525731 [TBL] [Abstract][Full Text] [Related]
29. Transdermal patch poisoning. Hamblin JE; Martin CA Pediatrics; 1987 Jan; 79(1):161. PubMed ID: 3797161 [No Abstract] [Full Text] [Related]
30. One hundred times the intended dose of caudal clonidine in three pediatric patients. Meyer C; Cambray R Paediatr Anaesth; 2008 Sep; 18(9):888-90. PubMed ID: 18482242 [TBL] [Abstract][Full Text] [Related]
31. Transdermal protein delivery by a coadministered peptide identified via phage display. Chen Y; Shen Y; Guo X; Zhang C; Yang W; Ma M; Liu S; Zhang M; Wen LP Nat Biotechnol; 2006 Apr; 24(4):455-60. PubMed ID: 16565728 [TBL] [Abstract][Full Text] [Related]
32. More than just an ocular solution. Pekdemir M; Yanturali S; Karakus G Emerg Med J; 2005 Oct; 22(10):753-4. PubMed ID: 16189050 [TBL] [Abstract][Full Text] [Related]
33. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance]. Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936 [TBL] [Abstract][Full Text] [Related]
34. Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats. Ishii R; Furuta M; Hashimoto M; Tagawa T; Naruse T; Hata T Arzneimittelforschung; 1998 Aug; 48(8):811-7. PubMed ID: 9748708 [TBL] [Abstract][Full Text] [Related]
35. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients]. Ambrosioni E Ann Ital Med Int; 1994 Oct; 9 Suppl():54S-57S. PubMed ID: 7857759 [TBL] [Abstract][Full Text] [Related]
36. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats. Miller PE; Rhaesa SL Am J Vet Res; 1996 Jan; 57(1):83-6. PubMed ID: 8720244 [TBL] [Abstract][Full Text] [Related]
37. Cephalad migration of intrathecal clonidine in an infant undergoing bilateral herniorrhaphy. Rakesh SV; Rajeev S; Batra YK; Rao KL Can J Anaesth; 2009 Aug; 56(8):629-30. PubMed ID: 19475467 [No Abstract] [Full Text] [Related]
38. Thioridazine withdrawal-induced behavioral deterioration treated with clonidine: two case reports. Sovner R Ment Retard; 1995 Aug; 33(4):221-5. PubMed ID: 7565144 [TBL] [Abstract][Full Text] [Related]
39. Person-to-person transfer of transdermal drug-delivery systems: a case report. Reed MT; Hamburg EL N Engl J Med; 1986 Apr; 314(17):1120-1. PubMed ID: 3960087 [No Abstract] [Full Text] [Related]
40. Transdermal clonidine for hypertension. Med Lett Drugs Ther; 1985 Oct; 27(700):95-6. PubMed ID: 4058369 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]